EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Circulating Micro-RNAs in Patients With Hypophosphatasia: Results of the First Micro-RNA Analysis in HPP

Judith Haschka iD, Zora Messner, Julia Feurstein, Benjamin Hadzimuratovic iD, Jochen Zwerina, Andreas B Diendorfer iD, Marianne Pultar, Matthias Hackl iD, Martin Kuzma, Juraj Payer, Heinrich Resch, Roland Kocijan

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf080 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Judith Haschka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hanusch Hospital, 1st Medical Department, Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1140 V…. Hauptthemen laut MEDLINE: Circulating MicroRNA, Hypophosphatasia, MicroRNAs. Die Arbeit nennt 56 Literaturangaben. Gefördert von: Alexion.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Adult hypophosphatasia (HPP) patients present with diffuse heterogenous symptoms often mimicking rheumatological diseases or osteoporosis and therefore accompanied by delayed diagnosis. The aim of this study was to identify circulating microRNAs (miRNAs) in adult HPP patients and to identify potential associations with clinical patients' characteristics.

Methods

We utilized untargeted miRNA biomarker discovery by small RNA-sequencing to investigate cell-free miRNA profiles in 24 adult HPP patients (pathogenic variant of the ALPL gene, HPP-related clinical symptoms, and repeatedly low alkaline phosphatase) and 24 healthy controls (CTRL).

Results

Patients and CTRL were comparable in age (47.9 ± 14.2 vs 45.9 ± 8.8 years, P = .980) and sex (55.5% vs 47.8% females, P = 1.000). In total, 91% of patients reported musculoskeletal pain, 41% diffuse neurological symptoms, and 64% history of fractures. In total, 84 miRNAs were significantly differently expressed between HPP and CTRL in next-generation sequencing analysis (P < .05). Of these, 14 miRNAs were selected (selection criteria: P < .05, tissue specificity index >0.7, log2 fold change >+0.8 or <−0.8) for validation using RT-qualitative PCR, which verified 6 of 14 selected miRNAs (P < .05; miR-122-3p, miR-140-5p, miR-143-3p, miR-155-5p, miR-451a, miR-92a-3p). Target prediction and enrichment analysis identified associations with the musculoskeletal system and the central nervous system. In total, 37 miRNAs correlated with alkaline phosphatase levels, but only 3 miRNAs with pyridoxal-5′-phosphate.

Conclusion

These findings highlight a profound involvement of multiple organ systems and the potential of miRNAs as biomarkers for the effect of HPP on various systems. Clinical Trials No NCT04018287

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating MicroRNAHypophosphatasiaMicroRNAsAdultFemaleHumansMaleMiddle AgedAlkaline PhosphataseBiomarkersCase-Control Studies

Stichwörter der Autor:innen

alkaline phosphatasehypophosphatasiamicro-RNA

Substanzen

Alkaline PhosphataseBiomarkersCirculating MicroRNAMicroRNAs

Autor:innen und Institutionen

  • Hanusch Hospital, 1st Medical Department, Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1140 Vienna, Austria.
  • Vienna Bone and Growth Center, Vienna, Austria.
  • Karl Landsteiner Institute for Osteology and Rheumatology, Rheuma-Zentrum Wien-Oberlaa, 1100 Vienna, Austria.
  • Barmherzige Schwestern Krankenhaus Wien, 2nd Medical Department, 1060 Vienna, Austria.
  • TAmiRNA GmbH, 1110 Vienna, Austria.
  • Comenius University Faculty of Medicine, University Hospital Bratislava, 81107 Bratislava, Slovakia.

ORCID-Profile: Judith Haschka, Benjamin Hadzimuratovic, Andreas B Diendorfer, Matthias Hackl

Förderung

  • Alexion

Zitieren

APA

Haschka, J., Messner, Z., Feurstein, J., Hadzimuratovic, B., Zwerina, J., Diendorfer, A. B., Pultar, M., Hackl, M., Kuzma, M., Payer, J., Resch, H., & Kocijan, R. (2025). Circulating Micro-RNAs in Patients With Hypophosphatasia: Results of the First Micro-RNA Analysis in HPP. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf080

Vancouver

Haschka J, Messner Z, Feurstein J, Hadzimuratovic B, Zwerina J, Diendorfer AB, et al. Circulating Micro-RNAs in Patients With Hypophosphatasia: Results of the First Micro-RNA Analysis in HPP. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf080

BibTeX
@article{Haschka2025,
  author = {Haschka, Judith and Messner, Zora and Feurstein, Julia and Hadzimuratovic, Benjamin and Zwerina, Jochen and Diendorfer, Andreas B and Pultar, Marianne and Hackl, Matthias and Kuzma, Martin and Payer, Juraj and Resch, Heinrich and Kocijan, Roland},
  title = {Circulating Micro-RNAs in Patients With Hypophosphatasia: Results of the First Micro-RNA Analysis in HPP},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf080}
}
Kostenlos starten →